Björn Schöttker

982 total citations
17 papers, 453 citations indexed

About

Björn Schöttker is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Björn Schöttker has authored 17 papers receiving a total of 453 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Björn Schöttker's work include Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Björn Schöttker is often cited by papers focused on Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (6 papers) and CAR-T cell therapy research (5 papers). Björn Schöttker collaborates with scholars based in Germany, United States and Austria. Björn Schöttker's co-authors include Ingo G.H. Schmidt‐Wolf, Angela Märten, Frank Schakowski, Peter Buttgereit, Carsten Ziske, Tilman Sauerbruch, Sabine Renoth, Marcus Gorschlüter, Alexander von Rücker and Burghardt Wittig and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Annals of Oncology.

In The Last Decade

Björn Schöttker

16 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Björn Schöttker Germany	10	247	209	170	85	38	17	453
Murrium Ahmad United Kingdom	13	244 1.0×	148 0.7×	141 0.8×	69 0.8×	38 1.0×	19	419
Korina G. Veenstra United States	6	317 1.3×	216 1.0×	139 0.8×	54 0.6×	40 1.1×	8	484
Casey A. Carlos United States	8	268 1.1×	159 0.8×	200 1.2×	102 1.2×	73 1.9×	12	502
Zane C. Neal United States	12	255 1.0×	167 0.8×	162 1.0×	62 0.7×	34 0.9×	17	445
H Sabzevari United States	6	366 1.5×	217 1.0×	158 0.9×	108 1.3×	29 0.8×	7	464
E Aruga United States	8	484 2.0×	283 1.4×	231 1.4×	80 0.9×	31 0.8×	9	646
Mara Valentini Italy	5	450 1.8×	379 1.8×	125 0.7×	47 0.6×	44 1.2×	5	643
Athanasia Syrengelas United States	6	590 2.4×	259 1.2×	246 1.4×	79 0.9×	39 1.0×	6	764
Uxua Mancheño Spain	14	350 1.4×	343 1.6×	192 1.1×	164 1.9×	38 1.0×	19	623
Samuel Alsén Sweden	9	513 2.1×	277 1.3×	191 1.1×	56 0.7×	43 1.1×	15	737

Countries citing papers authored by Björn Schöttker

Since Specialization

Citations

This map shows the geographic impact of Björn Schöttker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Schöttker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Schöttker more than expected).

Fields of papers citing papers by Björn Schöttker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Schöttker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Schöttker. The network helps show where Björn Schöttker may publish in the future.

Co-authorship network of co-authors of Björn Schöttker

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Schöttker. A scholar is included among the top collaborators of Björn Schöttker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Schöttker. Björn Schöttker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Riecke, Armin, Eugen Tausch, Deyan Y. Yosifov, et al.. (2023). Genetic markers and ibrutinib vs placebo treatment in early stage chronic lymphocytic leukemia -results from the GCLLSG CLL12 trial. Blood. 142(Supplement 1). 199–199.

2.

Fietz, Thomas, Thomas Decker, Volker Petersen, et al.. (2023). 407P Palbociclib plus endocrine therapy in HR+/HER2- advanced breast cancer patients: Interim results of the PERFORM study. Annals of Oncology. 34. S353–S354. 1 indexed citations

3.

Schöttker, Björn & Ingo G.H. Schmidt‐Wolf. (2011). Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells. PubMed. 9. Doc18–Doc18. 6 indexed citations

4.

Schöttker, Björn & Ingo G.H. Schmidt‐Wolf. (2011). Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells. SHILAP Revista de lepidopterología. 5 indexed citations

5.

Schöttker, Björn, Tobias Feuchtinger, Michael Schumm, et al.. (2008). Five donors–one recipient: modeling a mosaic of granulocytes, natural killer and T cells from cord-blood and third-party donors. Nature Clinical Practice Oncology. 5(5). 291–295. 14 indexed citations

6.

Schöttker, Björn, et al.. (2006). Parathyroid-hormone-related-protein-associated hypercalcemia in a patient with CLL-type low-grade leukemic B-cell lymphoma.. PubMed. 91(12 Suppl). ECR45–ECR45. 11 indexed citations

7.

Schakowski, Frank, Peter Buttgereit, Angela Märten, et al.. (2004). Novel non-viral method for transfection of primary leukemia cells and cell lines. PubMed. 2(1). 1–1. 61 indexed citations

8.

Schöttker, Björn, Andreas Dösch, & Doris Kraemer. (2003). Severe Hepatotoxicity after Application of Desloratadine and Fluconazole. Acta Haematologica. 110(1). 43–44. 6 indexed citations

9.

Gorschlüter, Marcus, Christian Hahn, Carsten Ziske, et al.. (2002). Low Frequency of Enteric Infections by Salmonella, Shigella, Yersinia and Campylobacter in Patients with Acute Leukemia. Infection. 30(1). 22–25. 9 indexed citations

10.

Märten, Angela, Dimitri Flieger, Sabine Renoth, et al.. (2002). Therapeutic vaccination against metastatic renal cell carcinoma by autologous dendritic cells: preclinical results and outcome of a first clinical phase I/II trial. Cancer Immunology Immunotherapy. 51(11-12). 637–644. 84 indexed citations

11.

Buttgereit, Peter, Frank Schakowski, Angela Märten, et al.. (2001). Effects of adenoviral wild-type p53 gene transfer in p53 -mutated lymphoma cells. Cancer Gene Therapy. 8(6). 430–439. 19 indexed citations

12.

Schakowski, Frank, Marcus Gorschlüter, Claas Junghans, et al.. (2001). A Novel Minimal-Size Vector (MIDGE) Improves Transgene Expression in Colon Carcinoma Cells and Avoids Transfection of Undesired DNA. Molecular Therapy. 3(5). 793–800. 79 indexed citations

13.

Märten, Angela, Carsten Ziske, Björn Schöttker, et al.. (2001). Transfection of dendritic cells (DCs) with the CIITA gene: increase in immunostimulatory activity of DCs. Cancer Gene Therapy. 8(3). 211–219. 13 indexed citations

14.

Märten, Angela, Carsten Ziske, Björn Schöttker, et al.. (2001). Interactions Between Dendritic Cells and Cytokine-Induced Killer Cells Lead to an Activation of Both Populations. Journal of Immunotherapy. 24(6). 502–510. 95 indexed citations

15.

Ziske, Carsten, Angela Märten, Björn Schöttker, et al.. (2001). Resistance of Pancreatic Carcinoma Cells Is Reversed by Coculturing NK-like T Cells with Dendritic Cells Pulsed with Tumor-Derived RNA and CA 19-9. Molecular Therapy. 3(1). 54–60. 26 indexed citations

16.

Märten, Angela, et al.. (2000). Increase of the Immunostimulatory Effect of Dendritic Cells by Pulsing With CA 19-9 Protein. Journal of Immunotherapy. 23(4). 464–472. 19 indexed citations

17.

Scheffold, Christian, Björn Schöttker, Petja Lefterova, et al.. (2000). Increased Sensitivity of Myeloid Leukemia Cell Lines: Potential of Lovastatin as Bone-Marrow-Purging Agent. Acta Haematologica. 104(2-3). 72–79. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact